|
Gemcitabin Clinical Trials
3 actively recruiting trials across 1 location
▲ +1 trial since September 2026
Pipeline
Phase 2: 1Phase 1/2: 1
Top Sponsors
- Peking University1
- Crescent Biopharma, Inc.1
- Blokhin's Russian Cancer Research Center1
Indications
- Cancer3
- BCG-Unresponsive Bladder Cancer1
- Biliary Tract Cancer (BTC)1
- Locally Advanced/Metastatic Solid Tumors1
- Non-Muscle Invasive Bladder Cancer1
Other2 trials
Birmingham, Alabama1 trial
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.